What drug interactions matter most with Keytruda (pembrolizumab)?
Keytruda (pembrolizumab) can interact with other treatments mainly through the way those treatments affect the immune system or cancer therapy plan—not through classic “metabolism” drug-drug interactions. The main interaction issues to check are:
- Other immune-stimulating or immune-suppressing drugs (because they can change immune activity and the risk of side effects).
- Corticosteroids and immunosuppressants used for other conditions (because they may affect how well immunotherapy works and how adverse effects are managed).
- Live vaccines and some vaccine timing around treatment.
- Drugs that increase immune-related adverse event risk are usually not “combined” by default; clinicians adjust based on your condition and history.
For the most precise interaction guidance, clinicians rely on the Keytruda prescribing information and your full medication list, including non-prescription products.
Can I take steroids or immunosuppressants with Keytruda?
Steroids are commonly used with immune checkpoint inhibitors, including Keytruda, to treat immune-related side effects (like colitis, hepatitis, or pneumonitis). Interaction considerations are mostly about intent and dose:
- If you are on steroids or other immunosuppressants for an underlying condition, your oncology team weighs risks and may adjust the plan based on the lowest effective dose needed to control your condition.
- If you start steroids to manage an immune-related adverse event, your clinician will follow a protocol that typically includes tapering when symptoms improve.
Because the effect depends strongly on dose and why you take them, it’s important to tell your prescriber exactly which steroid and dose you use and whether it’s for an autoimmune disease, lung disease, or another reason.
Do antibiotics, antivirals, or antifungals interact with Keytruda?
Most common antibiotics/antivirals/antifungals are not known for major direct interactions with pembrolizumab. The bigger issues tend to be:
- Whether those medicines are required for an active infection during cancer treatment.
- Whether infection symptoms overlap with immune-related side effects (for example, fever, cough, diarrhea), which can change how clinicians interpret side effects.
Even when there is no “direct interaction,” your oncology team may still adjust timing and monitoring based on your infection status and symptoms.
What vaccines should I avoid during Keytruda treatment?
Immune checkpoint therapy can change how you respond to vaccines. Practical interaction advice clinicians commonly follow includes:
- Avoid live vaccines while on treatment unless your oncology team explicitly approves.
- Inactivated vaccines may be used, but timing can matter (for example, around therapy cycles and when you are using higher-dose steroids for side effects).
If you’re planning travel or routine vaccines, ask your oncology team which vaccines are safe for your specific schedule.
Can Keytruda interact with blood thinners (warfarin, apixaban, rivaroxaban)?
There is no widely cited “must avoid” direct interaction pattern between pembrolizumab and anticoagulants, but there are still two important clinical realities:
- Immune-related adverse events can involve organs that can raise bleeding risk indirectly (for example, gastrointestinal inflammation).
- If you have abnormal liver function or other complications from treatment, clinicians reassess medication safety.
If you take warfarin or a direct oral anticoagulant, your prescriber should know so they can monitor for complications.
Are there interaction concerns with NSAIDs or pain medications?
Pain and symptom control is usually individualized. The primary concerns are typically not classic pharmacologic interactions with pembrolizumab but rather:
- Which adverse effects you have from Keytruda (for example, gastrointestinal symptoms that make NSAIDs riskier).
- Whether you’re using steroids or have immune-related inflammation that affects stomach, liver, or kidneys.
Tell your clinician if you have new abdominal pain, blood in stool, severe diarrhea, or liver-related symptoms before taking additional OTC medications.
What if I’m also taking other cancer therapies?
Combination regimens are chosen deliberately, and interaction risk depends on the specific partner therapy (chemotherapy, targeted therapy, radiation, or another immunotherapy). Clinicians monitor for overlapping side effects, especially:
- Increased immune-related toxicities.
- Additive risks to lungs, liver, GI tract, skin, and endocrine organs.
- Timing of radiation because symptoms can be hard to distinguish from immune adverse events.
If you share the exact other cancer medicines (names and doses), the interaction risks can be described more specifically.
What symptoms could be signs of an interaction or immune-related side effect?
Many “interaction-like” problems with Keytruda are actually immune-related adverse events triggered by treatment or amplified by certain co-therapies. Call your clinician urgently for symptoms such as:
- Shortness of breath, new or worsening cough (lung inflammation)
- Severe or persistent diarrhea or abdominal pain
- Yellow eyes/skin or dark urine (liver issues)
- Severe rash or blistering
- Severe fatigue with dizziness, headache, or confusion (endocrine or neurologic issues)
These aren’t proof of a drug interaction, but they are the kinds of symptoms that change medication decisions right away.
How to check Keytruda interactions safely
To get the right answer for your situation, gather:
- All prescription drugs (including cancer therapy partners)
- OTC drugs and supplements
- Recent antibiotics/antivirals
- Steroid dose and schedule (if applicable)
- Vaccines you received or plan to receive
- Any autoimmune history (which affects immunosuppression decisions)
Your oncology team/pharmacist can then screen for interaction issues and also interpret new side effects in context.
---
If you tell me the other medicines you’re taking (names and doses), I can map the most relevant Keytruda interaction concerns for that specific combination.
Sources
I can’t provide citations from the information provided so far. If you share the Keytruda prescribing information link or the drug list you’re considering, I can produce a sourced interaction-focused response.